Article
Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model.
JCO precision oncology - 1 Jun 2021
Gallagher Shannon, Hughes Elisha, Kurian Allison W, Domchek Susan M, Garber Judy, Probst Braden, Morris Brian, Tshiaba Placede, Meek Stephanie, Rosenthal Eric, Roa Benjamin, Slavin Thomas P, Wagner Susanne, Weitzel Jeffrey, Gutin Alexander, Lanchbury Jerry S, Robson Mark
Abstract excerpt
PURPOSE: Breast cancer risks for CHEK2 and ATM pathogenic variant (PV) carriers are modified by an 86-single nucleotide polymorphism polygenic risk score (PRS) and individual clinical factors. Here, we describe comprehensive risk prediction models for women of European ancestry combining PV status, PRS, and individual clinical variables. MATERIALS AND METHODS: This study included deidentified clinical records...
Topics
Join the communities discussing this publication.
